Free Trial

Dr. Martens (DOCS) Competitors

Dr. Martens logo
GBX 92.75 -0.10 (-0.11%)
As of 08:28 AM Eastern

DOCS vs. BLND, TEM, RMG, VTY, SPT, GEN, WIX, YOU, CNIC, and SST

Should you be buying Dr. Martens stock or one of its competitors? The main competitors of Dr. Martens include British Land (BLND), Templeton Emerging Markets Investment Trust (TEM), Royal Mail (RMG), Vistry Group (VTY), Spirent Communications (SPT), Genuit Group (GEN), Wickes Group (WIX), YouGov (YOU), CentralNic Group (CNIC), and Scottish Oriental Smaller Cos (SST). These companies are all part of the "computer software" industry.

Dr. Martens vs. Its Competitors

Dr. Martens (LON:DOCS) and British Land (LON:BLND) are both computer software companies, but which is the superior stock? We will contrast the two businesses based on the strength of their profitability, dividends, analyst recommendations, media sentiment, earnings, institutional ownership, risk and valuation.

Dr. Martens pays an annual dividend of GBX 0.02 per share and has a dividend yield of 0.0%. British Land pays an annual dividend of GBX 0.23 per share and has a dividend yield of 0.1%. Dr. Martens pays out 368.0% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. British Land pays out 65.4% of its earnings in the form of a dividend. British Land is clearly the better dividend stock, given its higher yield and lower payout ratio.

British Land has a net margin of 171.35% compared to Dr. Martens' net margin of 7.89%. Dr. Martens' return on equity of 18.91% beat British Land's return on equity.

Company Net Margins Return on Equity Return on Assets
Dr. Martens7.89% 18.91% 8.12%
British Land 171.35%18.53%3.37%

32.1% of Dr. Martens shares are held by institutional investors. Comparatively, 45.9% of British Land shares are held by institutional investors. 2.8% of Dr. Martens shares are held by insiders. Comparatively, 0.5% of British Land shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

British Land has lower revenue, but higher earnings than Dr. Martens. British Land is trading at a lower price-to-earnings ratio than Dr. Martens, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Dr. Martens£787.60M1.14£68.97M£0.0118,550.00
British Land£454M7.58£914.90M£0.35982.86

In the previous week, British Land had 1 more articles in the media than Dr. Martens. MarketBeat recorded 6 mentions for British Land and 5 mentions for Dr. Martens. British Land's average media sentiment score of 1.44 beat Dr. Martens' score of 0.85 indicating that British Land is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Dr. Martens
3 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
British Land
4 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Dr. Martens currently has a consensus target price of GBX 6,000, suggesting a potential upside of 6,369.00%. British Land has a consensus target price of GBX 480, suggesting a potential upside of 39.53%. Given Dr. Martens' higher probable upside, research analysts clearly believe Dr. Martens is more favorable than British Land.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Dr. Martens
0 Sell rating(s)
2 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.33
British Land
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00

Dr. Martens has a beta of 0.11, meaning that its share price is 89% less volatile than the S&P 500. Comparatively, British Land has a beta of 1.55, meaning that its share price is 55% more volatile than the S&P 500.

Summary

British Land beats Dr. Martens on 11 of the 17 factors compared between the two stocks.

Get Dr. Martens News Delivered to You Automatically

Sign up to receive the latest news and ratings for DOCS and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding DOCS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

DOCS vs. The Competition

MetricDr. MartensFootwear & Accessories IndustryCyclical SectorLON Exchange
Market Cap£895.66M£9.27B£3.90B£2.56B
Dividend Yield2.77%1.85%3.54%5.31%
P/E Ratio18,550.001,561.90524.755,419.53
Price / Sales1.1442.00229.3397,527.60
Price / Cash14.2920.2831.1627.93
Price / Book2.453.633.618.99
Net Income£68.97M£168.67M£264.31M£5.89B
7 Day Performance0.82%4.72%0.46%0.68%
1 Month Performance9.83%9.96%0.59%3.26%
1 Year Performance44.70%-2.20%34.65%186.78%

Dr. Martens Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
DOCS
Dr. Martens
2.4011 of 5 stars
GBX 92.75
-0.1%
GBX 6,000
+6,369.0%
+46.6%£895.66M£787.60M18,550.00890Dividend Cut
High Trading Volume
BLND
British Land
3.7629 of 5 stars
GBX 340
+0.5%
GBX 480
+41.2%
-25.0%£3.40B£454M971.431,690News Coverage
TEM
Templeton Emerging Markets Investment Trust
N/AGBX 205.18
+1.1%
N/A+36.2%£2.00B£187.20M1,428.83N/APositive News
High Trading Volume
RMG
Royal Mail
N/AN/AN/AN/A£1.98B£12.71B339.34100
VTY
Vistry Group
2.437 of 5 stars
GBX 603.80
-4.6%
GBX 594.80
-1.5%
-52.2%£1.95B£3.78B2,769.724,400
SPT
Spirent Communications
1.8074 of 5 stars
GBX 196.94
+0.8%
GBX 236
+19.8%
+14.1%£1.14B£471M15,882.101,526High Trading Volume
GEN
Genuit Group
3.3121 of 5 stars
GBX 339.50
-2.0%
GBX 507
+49.3%
-29.3%£843.87M£586.70M1,750.002,700
WIX
Wickes Group
2.2987 of 5 stars
GBX 195.20
-1.6%
GBX 222.50
+14.0%
+15.9%£452.19M£1.54B2,602.675,930Insider Trade
Gap Down
YOU
YouGov
3.6301 of 5 stars
GBX 360.09
+0.0%
GBX 662.50
+84.0%
-30.5%£421.99M£383.90M51,440.711,820
CNIC
CentralNic Group
N/AN/AN/AN/A£339.82M£790.04M-12,660.00100
SST
Scottish Oriental Smaller Cos
N/AGBX 295
-1.8%
N/A-79.9%£339.59M£38.69M1,060.24320Dividend Increase

Related Companies and Tools


This page (LON:DOCS) was last updated on 9/19/2025 by MarketBeat.com Staff
From Our Partners